Dianthus Therapeutics, Inc. (DNTH)
106.24
-0.38
(-0.36%)
USD |
NASDAQ |
Sep 02, 16:00
106.37
+0.13
(+0.12%)
After-Hours: 20:00
Dianthus Therapeutics Research and Development Expense (Annual) : 145.64M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 145.64M |
| December 31, 2024 | 83.10M |
| December 31, 2023 | 32.84M |
| December 31, 2022 | 29.38M |
| December 31, 2021 | 44.75M |
| Date | Value |
|---|---|
| December 31, 2020 | 48.64M |
| December 31, 2019 | 57.36M |
| December 31, 2018 | 41.34M |
| December 31, 2017 | 27.90M |
| December 31, 2016 | 5.782M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Legend Biotech Corp. | 415.80M |
| Ironwood Pharmaceuticals, Inc. | 93.26M |
| Verastem, Inc. | 114.60M |
| Fortress Biotech, Inc. | 11.90M |
| AbbVie, Inc. | 8.249B |